| Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells CVM Verhagen, R de Haan, F Hageman, TPD Oostendorp, ALE Carli, ... Radiotherapy and oncology 116 (3), 358-365, 2015 | 112 | 2015 |
| Onco-miR-21 promotes Stat3-dependent gastric cancer progression J Tse, T Pierce, ALE Carli, MG Alorro, S Thiem, EG Marcusson, M Ernst, ... Cancers 14 (2), 264, 2022 | 19 | 2022 |
| Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells ALE Carli, S Afshar‐Sterle, A Rai, H Fang, R O'Keefe, J Tse, FM Ferguson, ... Proteomics 21 (13-14), 2000098, 2021 | 19 | 2021 |
| Omicron BA. 2 specifically evades broad sarbecovirus neutralizing antibodies Y Cao, A Yisimayi, F Jian, T Xiao, W Song, J Wang, S Du, Z Zhang, P Liu, ... BioRxiv, 2022.02. 07.479349, 2022 | 9 | 2022 |
| Inhibition of the tuft cell/ILC2 axis reduces gastric tumor development in mice RN O’Keefe, ALE Carli, D Baloyan, S Afshar-Sterle, MF Eissmann, ... bioRxiv, 2022.02. 16.480779, 2022 | 7 | 2022 |
| A tuft cell-ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development RN O’Keefe, ALE Carli, D Baloyan, D Chisanga, W Shi, S Afshar-Sterle, ... Nature Communications 14 (1), 6872, 2023 | 3 | 2023 |
| Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3 P Thilakasiri, RN O’Keefe, SQ To, D Chisanga, MF Eissmann, ALE Carli, ... Life Science Alliance 7 (2), 2024 | 1 | 2024 |
| The kinase activity of the cancer stem cell marker DCLK1 drives gastric cancer progression by reprogramming the stromal tumor landscape S Afshar-Sterle, ALE Carli, R O’Keefe, J Tse, S Fischer, AI Azimpour, ... bioRxiv, 2022.04. 21.489109, 2022 | 1 | 2022 |
| A Mouse Model for the Rapid and Binomial Assessment of Putative WNT/β-Catenin Signalling Inhibitors J Tse, R O’Keefe, A Rigopolous, ALE Carli, J Waaler, S Krauss, M Ernst, ... Biomedicines 11 (10), 2719, 2023 | | 2023 |
| Structure-guided prediction of the functional impact of DCLK1 mutations on tumorigenesis ALE Carli, JM Hardy, H Hoblos, M Ernst, IS Lucet, M Buchert Biomedicines 11 (3), 990, 2023 | | 2023 |
